Navigation Links
Learning the Value of Prevention and Treatment in Oral Clefting

The burden of oral clefting leaves some with psychological problems into adulthood. A new study evaluating the impact of oral clefting on quality of life can be used to learn about the psychological //benefits and cost effectiveness of prevention and treatment.

Oral clefting is one of the most common birth defects. The impact of oral clefting can be substantial and can vary by age and type of clefting. Children born with clefts can experience challenging psychological adjustment because of low satisfaction with facial appearance as well as the lack of social skills acquired to enable adjustment. These developmental problems can extend through adulthood, affecting social and economic achievement in areas of marriage, education, and income level.

The study’s researchers chose to obtain Health-Related Quality of Life (HRQL) values related to oral clefting based on preferences of health professionals who serve on cleft palate and craniofacial teams in the United States. HRQL is the term used to describe the impact of health status on the quality of human life. It reflects a perception of the undesirability of health or disease conditions, stating their impact on quality of life, which includes physical functioning and comfort level, mental health, and social interactions.

Of the 330 professionals selected for the study, 40% returned the evaluation. Overall, high HRQL values were seen, which suggests a low burden of clefting on individual health and quality of life. However, this contradicts clinical and research evidence and experience that emphasizes the challenges introduced by this defect for all age groups.

Reasons offered by the authors for this contradiction include the following. The evaluators may not have understood the task of the study. Further, it is possible that too few psychologists and behavioral scientists were among the evaluators.

Examples of using the HRQL in the future may include cost-eff
'"/>




Page: 1 2

Related medicine news :

1. Habit Memory May Enhance Learning In People
2. Learning Just How Different We Are
3. Learning process to be regulated by altering brain protein
4. Better Research Rats To Help In Learning About Hypertension
5. Math Learning Disorder Higher in Boys
6. Math Learning Disorder Higher In Boys
7. Boys Suffer More Mathematics Learning Disorder Than Girls
8. Learning About Healthy Diet Choices Begins At Schools
9. Task Learning Made Simple By Taking Short Breaks
10. Novel Treatment to Cure People with Learning Disabilities
11. Study Shows Tomosyn Plays an Important Role in Learning and Memory
Post Your Comments:
(Date:7/22/2008)...n in lab, then returned to body, they could lead t...ly 22 (HealthDay News) -- Adult stem cells that ma... treatments for spinal cord injuries have been ide...eden. , They say it may be possible to develop ...o repair damaged nerve cells. , An adult,s spin...
(Date:7/21/2008)...K BROOK, Ill. The simple application of a pain-re...women experience during mammography exams, accordi... the online edition of Radiology . , "We now ha...screening mammography in women who expect higher d...l investigator, Colleen Lambertz, F.N.P., a nurse ...
(Date:7/21/2008)...n who take topiramate should discuss preconception...July 21 (HealthDay News) -- Pregnant women who use...ion with other epilepsy drugs may be increasing th...ort. , Topiramate (brand name Topamax) is a co...lepsy. It,s also used to treat migraine headaches....
(Date:7/21/2008)...RCESTER, Mass. For generations, people have consu...d off urinary tract infections, though the exact m...d. A new study by researchers at Worcester Polytec...s the thermodynamic properties of bacteria in the ...vents the microorganisms from getting close enough...
Breaking Medicine News(10 mins):Health News:Spinal Cord Stem Cells May Act as Nerve Repair System 2Health News:Over-the-counter anesthetic gel puts the squeeze on mammogram pain 2Health News:Epilepsy Drug May Boost Birth Defect Risk 2Health News:Epilepsy Drug May Boost Birth Defect Risk 3Health News:Cranberry juice creates energy barrier that keeps bacteria away from cells, study shows 2
...no use in losing weights and are not healthy attem...m the American Dietetic Association//. Dieticians ...g hours together at the local gym is no answer eit...e United States has caused concern among experts, ...
...tronics giant Samsung has developed a device that ...ice has four electrodes that the user touches with... a safe current through the body, measuring the vo...lows up one arm and down the other. A body fat va...
...rom malaria-prone Garo Hills region, Meghalaya Hea...h symptoms of the same disease. // Marak, who ret...d to the civil hospital here with malaria this mor... Health minister had accompanied chief minister J ...
... human cancers involve mutations in the p53 tumor-...ed by the normal p53 protein in defending// agains...causing mutations in the p53 protein occur in its ...his region of the p53 protein as being pivotal to ...
Other Medicine News:Health News:DNA-bound p53 Tumor Suppressor Protein Structure Determined 2
(Date:7/22/2008)...nstrates Feasibility and Efficacy of Treating Pati...ancer, SAN FRANCISCO, and YONGIN-SI, South Korea,...isco, CA and Ottawa, Ontario), and its South,Korea...novel findings from,a Phase I clinical trial of it...that the product was well-tolerated and resulted i...
(Date:7/22/2008)...ns Including Lantus(R) and Apidra(R) Resulted in S...e 2 Diabetes, Whatever the Algorithm ... 22 /- Results from the "Adjust to,Ta...gorithm to Carbohydrate,Counting for Adjustment of... in the American Diabetes Association,s (ADA) medi...
(Date:7/22/2008)... FRANCISCO, Calif., July 22 /- Hyperi...completed patient enrollment,in its Phase 1/2 clin...d,ammonia scavenging effects of HPN-100 (formally ...rate) in patients with urea cycle disorders,(UCD).... the fourth quarter,of this year., (Logo: http:/...
(Date:7/22/2008)...d and Validated by Columbia University Medical Cen...ry MicroRNA Technology, The Test Differentiates ...ncer (NSCLC), Classifying Squamous-Cell Carcinoma ...and Specificity of 90 Percent,This is the First CL...ivity as Biomarkers for Accurate Diagnosi...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Ingenious Med Reports Record Sales and Client Expansions in 2007 11028 1Ingenious Med Reports Record Sales and Client Expansions in 2007 11028 2Consumer Reports Poll 3A Americans Demand Health Reform But Are Unsure About How to Achieve it 11025 1Consumer Reports Poll 3A Americans Demand Health Reform But Are Unsure About How to Achieve it 11025 2Consumer Reports Poll 3A Americans Demand Health Reform But Are Unsure About How to Achieve it 11025 3Consumer Reports Poll 3A Americans Demand Health Reform But Are Unsure About How to Achieve it 11025 4Halogen Receives High Ratings from Bersin 26 Associates Company recognized as a market leader and receives praise for outstanding customer satisfa 3031 1Halogen Receives High Ratings from Bersin 26 Associates Company recognized as a market leader and receives praise for outstanding customer satisfa 3031 2Stevens researchers provide oversight for three year mariculture program in Egypt and Israel 2118 1
..., 2007 /PRNewswire/ -- Portola,Pharmaceuticals, In...nd preclinical data on its oral Factor Xa inhibito...agonist at the XXI Congress of,the International S...eva, Switzerland on July 6 through July 12, 2007. ...on the Company,s,lead compound PRT054021, is entit...
... -- Ablynx today announced positive,interim result...opment programme, ALX-0081, an anti-thrombotic tre...acute; therapeutic,Nanobody® targeting von Wil... thrombosis in patients with acute coronary,syndro...esigned to assess,safety, tolerability and pharmac...
Other Medicine Technology:Portola Pharmaceuticals Announces Positive Phase II EXPERT Results,and Additional Oral and Poster Presentations at the XXI Congress of,the International Society on Thrombosis and Haemostasis (ISTH) 2Portola Pharmaceuticals Announces Positive Phase II EXPERT Results,and Additional Oral and Poster Presentations at the XXI Congress of,the International Society on Thrombosis and Haemostasis (ISTH) 3Ablynx Announces Interim Results of First Nanobody Phase I Study of,ALX-0081 (ANTI-VWF) 2
With this unique offer, you can prepare for any molecular biology application. Pipetman P2 and P10 are ideal for enzymes and reagents, and P100 is perfect for buffers. Kits include Diamond Filter Tip
...ant Rapid Opiate II Rapid Opiates is an immunochro...igned for qualitative determination of Opiates and...ence of morphine in human urine above a cut-off le...not been evaluated in the point of care,location a...
The RapidTHC test is an immunochromatography based one step in vitro test. It is,designed for qualitative determination of THC and its metabolites in human urine,specimens. The presence of 11-nor-? 9
The RapidBARBITURATE test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of barbiturates and in human urine specimens above a cut-off level of 3
Medicine Products: